the national volume|based procurement policy in China

Challenges and countermeasures for China's centralised volume ...

To reduce the cost of healthcare expenditures in China, the government has developed a centralised volume-based procurement (CVBP) policy ...

Improving access to medicines and beyond: the national volume ...

... China's central government formally enforced a national volume-based procurement (NVBP) policy on 1 January 2019. By consolidating national purchasing power ...

the national volume-based procurement policy in China - OUCI

Since 2019, the Chinese central government has taken significant steps to centralize national purchasing power and has implemented a pooled procurement ...

China to ramp up volume-based procurement policies for drugs and ...

China will continue to ramp up volume-based procurement (VBP) policies that bring down drug and device prices for public hospitals with ...

Pricentric Insights: China Issues New Volume-Based Procurement ...

VBP will center on National Reimbursement Drug List (NRDL)-listed drugs with large purchase volume and high purchase value. Eventually, all ...

China's 4th Volume Based Procurement (VBP) Dramatically ...

China's VBP program looks to reduce pricing by awarding large volume sales to tender winners. In early December, the National Healthcare ...

The impact of National Centralized Drug Procurement policy on the ...

➢ The “4+7” policy is the first policy attempt of volume-based drug procurement work at the national level in China, and is a pioneering work in ...

Untitled

China's 9th Volume-based Procurement (VBP) of Drugs to Impact ...

13, 2023, China's National Joint Drug Procurement Office announced a list of 42 drugs1 (based on active pharmaceutical ingredients) for the ...

China Announces Final Result of the 7th Volume-based ...

On July 18, China National Joint Drug Procure Office announced the official list of 327 products for the 7th volume-based procurement (VBP).

PNS40 The Implementation of Volume-Based Drug Procurement ...

Volume-based drug procurement program was proposed in China last year, as a national strategy to optimize drug pricing.

Volume-based procurement is shaking up high-value medical ...

The VBP policy integrates a larger purchasing volume with a lower price, to suppress the inflated prices of high-value medical devices.

PDG39 CHALLENGE OR OPPORTUNITY? THE EXPANSION OF ...

Aiming to reduce generic drug expenditure, optimize Basic Medical Insurance fund and ensure drug quality, Chinese payer introduced volume-based procurement ...

China Kicks off the 7th Round of Volume-based Procurement (VBP ...

On June 20, China National Joint Drug Procurement Office announced the start of the 7th round of volume-based procurement (VBP), ...

4+7: China's New Volume-Based Purchasing Policy

In late 2018 China adopted a novel procurement scheme with the aim of dramatically cutting the amount being paid for generic drugs.

IVD Makers Brace for Potential Impact From China Volume-Based ...

The program, which involves government contracts for certain types of in vitro diagnostic testing, could determine which companies thrive in ...

Influence of Chinese National Centralized Drug Procurement on the ...

It is necessary to further expand the scope of centralized purchased drugs and strengthen the monitoring of related drugs regarding price change and ...

Policy briefing on Opinions on Promoting Regular and Regulated ...

Policy briefing about Opinions on Promoting Regular and Regulated Volume-based Procurement of Pharmaceuticals Beijing | 3 p.m. Jan. 29, 2021. Speakers. Chen ...

The pan-Canadian Tiered Pricing Framework and Chinese National ...

NVBP is a downstream national initiative prioritised for reducing drug prices to achieve value-based purchasing. Process: By associating the ...

Effect of centralized volume-based procurement of drugs on ...

In January 2022, the State Council of China decided to “normalize and institutionalize the centralized procurement with quantity control for ...